Workshop on advanced therapy medicinal products
Client: European Parliament
Milieu Ltd supported the Directorate General for Internal Policies of the European Parliament in the organisation of the workshop on ‘Advanced Therapy Medicinal Products’. In the context of the EU policy on advanced therapies (Regulation on advanced therapies (EC) 1394/2007, the aim of the workshop was to exchange views on the opportunities and challenges related to advanced therapy treatment, including cell and gene therapies.
The workshop also discussed the economic costs of bringing healthcare research to the market. The workshop was hosted by Ms Glenis WILLMOTT (MEP) and Mr Alojz PETERLE (MEP), Co-chairs of the Health Working Group within the ENVI Committee.
Milieu Ltd provided logistical support to the European Parliament for the organisation of the workshop. Milieu staff identified and contacted experts with extensive experience in the area of advanced therapy treatment and biotechnology transfer as well as arranged their participation.
Milieu staff drafted the press releases for the workshop (both before and after the workshop) and the final workshop report.
The workshop discussion informed the debate on the application of the Regulation on advanced therapies which was currently under review by the European Commission.
A public consultation was launched, and was open until 31 March 2013, to collect stakeholders’ views on this matter. The results of the consultation fed into a report published by the Commission in mid-2013.